Global Ophthalmology Drugs And Devices Market Size By Product Type (Anti-inflammatory, Anti-glaucoma), By Application (Dry Eye, Eye Allergy), By End-User (Hospitals, Medical Clinics), By Geographic Scope And Forecast
Report ID: 69397|No. of Pages: 202
Global Ophthalmology Drugs And Devices Market Size By Product Type (Anti-inflammatory, Anti-glaucoma), By Application (Dry Eye, Eye Allergy), By End-User (Hospitals, Medical Clinics), By Geographic Scope And Forecast
Ophthalmology Drugs And Devices Market Size And Forecast
Ophthalmology Drugs And Devices Market size was valued at USD 57.02 Billion in 2024 and is projected to reach USD 88.18 Billion by 2031, growing at a CAGR of 5.60% from 2024 to 2031.
The increasing prevalence of eye diseases and disorders, rising health awareness among people about the same, presence of a robust pipeline of molecules, and increase in adoption of ophthalmology drugs and devices are driving the growth of the Global Ophthalmology Drugs And Devices Market significantly. The Global Ophthalmology Drugs And Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Ophthalmology Drugs And Devices Market Definition
Ophthalmology is a field of medical science that focuses on the diagnosis and treatment of eye disorders. Ophthalmic devices are used in a variety of procedures such as cataract surgery, glaucoma surgery, and refractive surgery. Ophthalmic drugs are used to treat a wide range of eye diseases, including infection, glaucoma, and cataract. The Global Ophthalmology Drugs And Devices Market is experiencing significant growth because of the rising incidence and prevalence of eye-related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the geriatric population. With the advent of sophisticated ophthalmic devices, people are increasingly going to opt for ophthalmic surgeries to cure their eye-related disorders.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=69397
Global Ophthalmology Drugs And Devices Market Overview
The Global Ophthalmology Drugs And Devices Market is expected to experience remarkable growth in the upcoming years owing to the increasing demand for minimally invasive surgeries in the treatment of various eye-related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the geriatric population. The increasing incidence and prevalence of eye diseases and disorders, rising health awareness among people about the same, presence of a robust pipeline of molecules, and increase in adoption of ophthalmology drugs and devices in the treatment and diagnosis of certain ocular malformations and eye deficits are fueling the growth of Global Ophthalmology Drugs And Devices Market significantly.
Additionally, technological advancement in the field of Ophthalmology Drugs and Devices and increasing investment in R&D activities for the development of new ophthalmological drugs are also promoting market growth. Furthermore, the rise in the geriatric population across the globe, increasing ophthalmic disorders due to high blood sugar, growth in the healthcare sector, and increasing government initiatives and support in the form of funds and grants for diagnostic equipment and treatment procedures, also boost the growth of the Ophthalmology Drugs And Devices Market.
Moreover, an increase in the patient population of eye-related disorders, increasing product development and launch activities, huge demand for intraocular lenses and phacoemulsification devices, and growth potential in developing nations are expected to provide profitable growth opportunities to the market players in the Global Ophthalmology Drugs And Devices Market during the forecast period. However, high cost associated with the treatment procedures, drug approval delays wherein multiple drugs are in the pipeline, low awareness of ophthalmic drugs, lack of skilled healthcare professionals, and patent expiry is expected to hinder the growth of the Global Ophthalmology Drugs And Devices Market over the forecast period. In addition, risks associated with ocular disease treatment are posing challenges to the growth of the Ophthalmology Drugs And Devices Market.
Global Ophthalmology Drugs And Devices Market Segmentation Analysis
The Global Ophthalmology Drugs And Devices Market is Segmented on the basis of Product Type, Application, End-User, and Geography.
Ophthalmology Drugs And Devices Market, By Product Type
- Anti-allergy
- Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents
- Anti-inflammatory
- Anti-glaucoma
- Diagnostic and Monitoring Devices
- Surgical Devices
- Vision Care
- Others
Based on Product Type, the market is bifurcated into Anti-allergy, Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents, Anti-inflammatory, Anti-glaucoma, Diagnostic and Monitoring Devices, Surgical Devices, Vision Care, and Others. The anti-inflammatory segment accounts for the highest revenue share of the Global market in 2020 and is expected to dominate the market over the forecast period owing to an increase in the prevalence of allergic conjunctivitis and hypersensitivity reactions, as well as an increase in demand for anti-inflammatory drugs in a wide range of conditions such as uveitis, cystoid macular edema, and scleritis. These factors are driving the growth of this segment.
Ophthalmology Drugs And Devices Market, By Application
- Dry Eye
- Eye Allergy
- Glaucoma
- Cataract
- Eye Infection
- Retinal Disorders
- Uveitis
- Others
Based on Application, the market is bifurcated into Dry Eye, Eye Allergy, Glaucoma, Cataract, Eye Infection, Retinal Disorders, Uveitis, and Others. The retinal disorders segment is expected to hold the largest revenue share of the global market during the forecast period owing to the rise in the geriatric population, increase in the prevalence of macular degeneration, and an increase in the sale of ophthalmic drugs for the treatment of retinal disorders. However, the glaucoma segment is expected to grow significantly during the forecast period due to an increase in glaucoma prevalence, a rising need for ophthalmic drugs, and an increase in glaucoma prevention and treatment awareness.
Ophthalmology Drugs And Devices Market, By End-User
- Hospitals
- Medical Clinics
- Diagnostic Centers
- Others
Based on End-User, the market is bifurcated into Hospitals, Medical Clinics, Diagnostic Centers, and Others. The hospitals segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various eye-related disorders, and rising awareness about these disorders. Additionally, the availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled eye care professionals are driving the growth of the global market in the hospitals segment.
Ophthalmology Drugs And Devices Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
On the basis of Regional Analysis, The Global Ophthalmology Drugs And Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Among the regional markets, North America accounts for the largest revenue share in the Global Ophthalmology Drugs And Devices Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to the increased investment in R&D activities for the development of technologically advanced medical devices and innovative drugs for the treatment of various eye-related disorders.
Additionally, the increasing geriatric population, rising incidence and prevalence of various eye-related disorders, rising healthcare sectors, presence of skilled eye care professionals, and wide availability of technologically advanced ophthalmology devices are the major factors that boost the Ophthalmology Drugs And Devices Market growth across the region. The market in the Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period, owing to the increasing focus on the development of healthcare infrastructure and the rising prevalence of various eye-related disorders such as glaucoma and cataract in developing nations such as China, and India in this region.
Key Players
The “Global Ophthalmology Drugs And Devices Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Carl Zeiss AG, Novartis AG, Johnson And Johnson Services, Inc., Allergan, Topcon Corporation, Nidek Co., Ltd., HAAG-STREIT GROUP, Ziemer Ophthalmic Systems, Bausch And Lomb Incorporated, Biotech, VisionCare, Inc., Akorn, Incorporated, Bayer AG, Acucela Inc., Regeneron Pharmaceuticals, Inc, Nicox, Santen Pharmaceutical Co., Ltd. and IRIDEX Corporation, Alcon Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
- In August 2020, Topcon Corporation purchased the Henson line of perimetry products, including the Henson 9000 and 7000, from the United Kingdom-based Elektron Eye Technology (EET) of Cambridge.
- In January 2020, iCare’s IC200 tonometer device was approved by the US FDA.
- In March 2019, Alcon Inc. acquired Power Vision Inc., a privately held medical device development company based in the United States that specializes in fluid-based intraocular lens implants.
- In August 2018, CEQUA, developed by Sun Pharmaceutical Industries Ltd., had been approved by the US FDA for the treatment of dry eye diseases.
- In July 2018, Amring Pharmaceuticals, Inc. introduced Biolon ophthalmic viscosurgical devices for cataract surgeons in the United States.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2021-2023 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Carl Zeiss AG, Novartis AG, Johnson & Johnson Services, Inc., Allergan, Topcon Corporation, Ziemer Ophthalmic Systems, Bausch & Lomb Incorporated, Biotech. |
| Segments Covered | By Product Type, By Application, By End-User, And By Geography |
| Customization Scope | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET, BY PRODUCT TYPE
5.1 Overview
5.2 Anti-allergy
5.3 Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents
5.4 Anti-inflammatory
5.5 Anti-glaucoma
5.6 Diagnostic and Monitoring Devices
5.7 Surgical Devices
5.8 Vision Care
5.9 Others
6 GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET, BY APPLICATION
6.1 Overview
6.2 Dry Eye
6.3 Eye Allergy
6.4 Glaucoma
6.5 Cataract
6.6 Eye Infection
6.7 Retinal Disorders
6.8 Uveitis
6.9 Others
7 GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET, BY END-USER
7.1 Overview
7.2 Hospitals
7.3 Medical Clinics
7.4 Diagnostic Centers
7.5 Others
8 GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Middle East and Africa
8.5.2 Latin America
9 GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 COMPANY PROFILES
10.1 Carl Zeiss AG
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Novartis AG
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Johnson and Johnson Services, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Allergan
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Alcon Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Topcon Corporation
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Nidek Co., Ltd.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Bausch and Lomb Incorporated
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Bayer AG
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
9.10 Santen Pharmaceutical Co., Ltd.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
11 Appendix
11.1.1 Related Reports
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
